申请人:Bayer Aktiengesellschaft
公开号:US04876255A1
公开(公告)日:1989-10-24
For the control of coronary diseases and thromboses there are provided the novel compounds ##STR1## in which R.sup.1 is an optionally substituted phenyl or heterocyclic radical, R.sup.2 is a cyano, keto, carboxy, ester or amide group, and X is from 0 to 6, and physiologically acceptable salts thereof.
为了控制冠心病和血栓形成,提供了新的化合物##STR1## 其中R.sup.1是可选择的取代苯基或杂环基团,R.sup.2是氰基,酮基,羧基,酯基或酰胺基,X为0至6,以及其生理上可接受的盐。